The association of lung function and pulmonary vasculature volume with cardiorespiratory fitness in the community.


Journal

The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460

Informations de publication

Date de publication:
08 2022
Historique:
received: 29 06 2021
accepted: 06 12 2021
pubmed: 9 1 2022
medline: 9 8 2022
entrez: 8 1 2022
Statut: epublish

Résumé

Cardiorespiratory fitness is not limited by pulmonary mechanical reasons in the majority of adults. However, the degree to which lung function contributes to exercise response patterns among ostensibly healthy individuals remains unclear. We examined 2314 Framingham Heart Study participants who underwent cardiopulmonary exercise testing (CPET) and pulmonary function testing. We investigated the association of forced expiratory volume in 1 s (FEV We found lower FEV In a large, community-based cohort of adults, we found lower FEV

Sections du résumé

BACKGROUND
Cardiorespiratory fitness is not limited by pulmonary mechanical reasons in the majority of adults. However, the degree to which lung function contributes to exercise response patterns among ostensibly healthy individuals remains unclear.
METHODS
We examined 2314 Framingham Heart Study participants who underwent cardiopulmonary exercise testing (CPET) and pulmonary function testing. We investigated the association of forced expiratory volume in 1 s (FEV
RESULTS
We found lower FEV
CONCLUSIONS
In a large, community-based cohort of adults, we found lower FEV

Identifiants

pubmed: 34996832
pii: 13993003.01821-2021
doi: 10.1183/13993003.01821-2021
pmc: PMC9259762
mid: NIHMS1801341
pii:
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL140224
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL131029
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201500001C
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL136905
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL159514
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201500001I
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92019D00031
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL138260
Pays : United States
Organisme : NHLBI NIH HHS
ID : F32 HL143819
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL151841
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC25195
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL153669
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL134893
Pays : United States

Informations de copyright

Copyright ©The authors 2022. For reproduction rights and permissions contact permissions@ersnet.org.

Déclaration de conflit d'intérêts

Conflict of interest: J. McNeill has nothing to disclose. Conflict of interest: A. Chernofsky has nothing to disclose. Conflict of interest: M. Nayor reports grants from the NIH, during the conduct of the study. Conflict of interest: F.N. Rahaghi has nothing to disclose. Conflict of interest: R. San Jose Estepar has contracts with Lung Biotechnology, Insmed and Boehringer Ingelheim, receives consulting fees from Leuko Labs, and has stock options in Quantitative Imaging Solutions. Conflict of interest: G. Washko reports grants from the NIH, DoD, Boehringer Ingelheim, Janssen Pharmaceuticals, BTG Therapeutics, Pulmonx, Lung Biotechnology and Insmed; participation in advisory boards and consultancies for Boehringer Ingelheim, CSL Behring, Novartis, Phillips and Vertex Pharmaceuticals; is a co-founder and equity shareholder in Quantitative Imaging Solutions, a company that provides consulting services for image and data analytics; finally, the author's spouse works for Biogen. Conflict of interest: A. Synn reports grants from the American Lung Association and NHLBI, outside the submitted work. Conflict of interest: R.S. Vasan has nothing to disclose. Conflict of interest: G. O'Connor has nothing to disclose. Conflict of interest: M.G. Larson has nothing to disclose. Conflict of interest: J.E. Ho reports grants from the NIH/NHLBI, during the conduct of the study; research support from Gilead Sciences and Bayer AG, and research supplies from EcoNugenics, outside the submitted work. Conflict of interest: G.D. Lewis reports grants from Amgen, Cytokinetics, AstraZeneca, Applied Therapeutics and Sonivie, personal fees and other for advisory board work from American Regent, outside the submitted work.

Références

Circ Heart Fail. 2020 May;13(5):e006729
pubmed: 32362167
Med Sci Sports Exerc. 1986 Apr;18(2):143-55
pubmed: 3517547
J Am Coll Cardiol. 2018 Sep 4;72(10):1109-1122
pubmed: 30165982
J Am Coll Cardiol. 2018 Aug 28;72(9):987-995
pubmed: 30139444
Circulation. 1991 Mar;83(3):778-86
pubmed: 1999029
J Appl Physiol (1985). 2010 Nov;109(5):1307-17
pubmed: 20724567
Eur Respir J. 2018 Jan 31;51(2):
pubmed: 29386347
JAMA. 2009 May 20;301(19):2024-35
pubmed: 19454641
Respir Res. 2015 Dec 30;16:156
pubmed: 26715058
Eur Respir J. 2019 Sep 12;54(3):
pubmed: 31248956
Am J Respir Crit Care Med. 2013 Jul 15;188(2):231-9
pubmed: 23656466
Eur Respir J. 2019 Aug 15;54(2):
pubmed: 31196942
Arch Intern Med. 1979 Aug;139(8):857-61
pubmed: 464698
Congest Heart Fail. 2000 Sep-Oct;6(5):256-258
pubmed: 12189286
Obesity (Silver Spring). 2014 Nov;22(11):2441-9
pubmed: 25136837
BMC Pulm Med. 2019 Jan 6;19(1):2
pubmed: 30612551
Am J Epidemiol. 2007 Jun 1;165(11):1328-35
pubmed: 17372189
JAMA. 2003 Sep 24;290(12):1600-7
pubmed: 14506119
Am J Respir Crit Care Med. 1995 Sep;152(3):1107-36
pubmed: 7663792
Circulation. 2016 Dec 13;134(24):e653-e699
pubmed: 27881567

Auteurs

Jenna McNeill (J)

Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
These four authors are co-authors.

Ariel Chernofsky (A)

Boston University and National Heart, Lung, and Blood Institute Framingham Heart Study, Framingham, MA, USA.
Biostatistics Dept, Boston University School of Public Health, Boston, MA, USA.
These four authors are co-authors.

Matthew Nayor (M)

Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Farbod N Rahaghi (FN)

Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Raul San Jose Estepar (R)

Division of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

George Washko (G)

Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Andrew Synn (A)

Division of Pulmonary and Critical Care Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Ramachandran S Vasan (RS)

Framingham Heart Study and Sections of Preventive Medicine and Epidemiology and Cardiovascular Medicine, Boston University School of Medicine, and Dept of Epidemiology, Boston University School of Public Health, Boston, MA, USA.

George O'Connor (G)

Framingham Heart Study and Sections of Preventive Medicine and Epidemiology and Cardiovascular Medicine, Boston University School of Medicine, and Dept of Epidemiology, Boston University School of Public Health, Boston, MA, USA.

Martin G Larson (MG)

Boston University and National Heart, Lung, and Blood Institute Framingham Heart Study, Framingham, MA, USA.
Biostatistics Dept, Boston University School of Public Health, Boston, MA, USA.

Jennifer E Ho (JE)

Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, USA jho@bidmc.harvard.edu.
These four authors are co-authors.

Gregory D Lewis (GD)

Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
These four authors are co-authors.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH